Sales calls up for Novartis, down overall

Novartis is bucking the trend toward fewer sales calls to healthcare professionals.
 

ASCO Post launches in print, and online

The American Society of Clinical Oncology (ASCO) and Harborside Press launched the inaugural print issue of ASCO Post in June, and launched a website home for the title yesterday.
 

FTC did not abuse power in Watson brouhaha, judge opines

A judge magistrate said that federal antitrust officials did not overstep or share confidential information while probing whether Cephalon illegally settled patent disputes with Watson Pharmaceuticals and others, but he disagreed with the way antitrust officials conducted the investigation.
 

Roche issues social media rules

Roche released guidelines for company use of social media, saying that "social media's high speed, level of interactivity and global access to any information you publish merits particular consideration to the appropriate uses for these applications."
 

SequenceDoc portal to deliver custom journals for docs

Custom media provider Sequence Personal, and CMI, have partnered to create SequenceDoc, a portal for physicians offering tailored medical content served up as an on-demand print journal, or as a digital download.
 

Abbott launches website, widget for psoriasis awareness

Abbott launched a psoriasis educational website and a widget, the latter offering weekly tips and facts delivered to the user's personal desktop.
 

PDI exiting TVG market-research unit; founder asks, could mega-agencies be next?

Citing decreased demand, pharmaceutical promotional support firm PDI said it intends to exit its TVG Marketing Research & Consulting business unit by month's end.
 

Good Health Media and Tynt target copy and paste keywords

Visitors who copy and paste keywords on any of Good Health Media's 140 web properties will prompt a box of sponsored links, courtesy of Tynt Multimedia technology.
 

Dendreon draws CBER letter for Provenge professional marketing

The Center for Biologics Evaluation and Research hit Dendreon with an untitled letter for false and misleading professional marketing materials for its prostate cancer treatment Provenge.
 

CME sea change is also a way to cut deaths from pain drugs

At a recent FDA advisory hearing on ways to increase the safety of extended-release and long-acting opioid drugs, the agency opened the door to using continuing medical education (CME) to help reach the goal.